ALTUV — Bio-UV SA Income Statement
0.000.00%
- €19.85m
- €39.97m
- €39.58m
- 38
- 74
- 65
- 64
Annual income statement for Bio-UV SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.2 | 33.5 | 51.3 | 43.1 | 39.6 |
Cost of Revenue | |||||
Gross Profit | 10.2 | 11.9 | 16.8 | 15.4 | 14.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 31.2 | 32.7 | 47.4 | 41.8 | 38.5 |
Operating Profit | 1.02 | 0.751 | 3.87 | 1.36 | 1.06 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.554 | 0.631 | 3 | 0.016 | 0.092 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.584 | 0.689 | 2.42 | 0.125 | 0.031 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.584 | 0.689 | 2.42 | 0.125 | 0.031 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.584 | 0.689 | 2.42 | 0.125 | 0.031 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.099 | 0.073 | 0.265 | 0.072 | 0.07 |
Dividends per Share | |||||
Special Dividends per Share |